Scheme Profile

Tata Mid Cap Growth Fund - (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
4,444
Inception Date
05-04-1996
Category
Equity - Mid Cap

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 5000
  • 52 Week High / Low ()
  • 460.1918 (27-Sep-2024) / 323.1633 (22-Nov-2023)
  • Incremental Investment ()
  • 1000
  • NAV ()
  • 418.13 ( 1.69) ( 0.41 %)
  • Benchmark
  • Nifty Midcap 150 TRI
  • Entry Load
  • NIL
  • Exit Load
  • On or before expiry of 365 days from the date allotment: If the withdrawal amount or switched out amount is not more than 12% of the original cost of investment: Nil On or before expiry of 365 days from the date of allotment: If the withdrawal amount or switched out amount is more than 12% of the original cost of investment: 1% Redemption after expiry of 365 days from the date of allotment: Nil
  • Expense Ratio (%)
  • 2.58
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 53.47 times
  • Portfolio P/B
  • 7.86 times
  • Average Maturity
  • -
  • Yield To Maturity
  • -
  • Modified Duration
  • -
  • Turnover Ratio (%)
  • 34.22

Risk Factors

  • Jenson's Alpha
  • 0.25
  • Standard Deviation
  • 3.85
  • Beta
  • 0.87
  • Sharpe
  • 1.17
  • R-Squared
  • 1.00
  • Treynor Factor
  • 0.15

NAV Movement

AUM Growth ( Cr.)

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • Nifty Midcap 150 TRI
  • 18.59
  • -4.99
  • 4.75
  • 30.69
  • 21.97
  • 27.62
  • 18.64
  • -

Company Top 5 Holdings

  [ As on 31 Oct 2024 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Max Financial Services Ltd
  • Equity
  • 13,00,000
  • 3.75
  • Reverse Repo
  • Reverse Repo
  • 0
  • 3.42
  • Alkem Laboratories Ltd
  • Equity
  • 2,50,000
  • 3.25
  • Aurobindo Pharma Ltd
  • Equity
  • 10,00,000
  • 3.14
  • Muthoot Finance Ltd
  • Equity
  • 7,00,000
  • 3.04

Sector Top 5 Holdings

  [ As on 31 Oct 2024 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 63,31,612
  • 13.76
  • Finance
  • 47,98,000
  • 11.63
  • Capital Goods-Non Electrical Equipment
  • 8,82,286
  • 6.50
  • Banks
  • 1,85,08,624
  • 5.77
  • IT - Software
  • 15,70,000
  • 5.49

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD 19.86 23.20 18.59 7.34 4,443.96
2023 39.89 36.41 43.59 18.10 3,040.51
2022 -0.42 1.11 2.76 2.80 1,778.05
2021 38.99 41.58 46.48 21.69 1,516.61
2020 23.86 26.12 25.12 15.60 1,010.59
2019 6.92 3.33 0.58 13.79 772.96
2018 -12.80 -11.09 -12.49 6.67 639.25
2017 48.38 40.61 54.36 28.06 733.06
2016 -2.73 3.67 5.47 1.78 515.16
2015 9.76 8.34 9.28 -5.05 563.31

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Sep-2024 4.23 6.93 6.31 6.07 4,636.68
Jun-2024 16.35 16.88 15.32 6.78 4,193.89
Mar-2024 4.53 4.38 3.59 1.91 3,348.40
Dec-2023 10.85 11.48 12.62 10.27 3,040.51

Peer Comparison

<< < 12> >> 

Asset Allocation

Sector Allocation

Close